YML009W-B Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to YML009W-B Antibody

The YML009W-B Antibody (Product Code: CSB-PA715288XA01SVG) is a custom polyclonal antibody developed for research applications targeting the protein encoded by the YML009W-B gene in Saccharomyces cerevisiae (Baker’s yeast). This antibody is cataloged under UniProt accession number Q6B0Y1 and is available in two sizes (0.1 ml and 1.0 ml) . Antibodies like YML009W-B are critical tools for studying gene function, protein localization, and molecular interactions in yeast models, which are widely used to understand eukaryotic cellular processes .

Target Antigen Characteristics

The YML009W-B gene resides on chromosome XIII of S. cerevisiae. While functional annotations for this specific protein remain limited, yeast gene nomenclature (YML = Yeast Middle Left arm) suggests its chromosomal location. The encoded protein is hypothetical, with no explicit functional domains identified in the provided data. Antibodies like YML009W-B enable researchers to empirically investigate its role in cellular pathways, such as metabolism or stress response, through techniques like knockout studies or protein interaction mapping .

4.1. Functional Studies

  • Protein Localization: Antibodies against yeast proteins are frequently used to determine subcellular localization via immunofluorescence . For YML009W-B, this could clarify whether the protein is membrane-bound, cytoplasmic, or nuclear.

  • Interaction Networks: Co-immunoprecipitation (Co-IP) paired with mass spectrometry could identify binding partners, elucidating its role in macromolecular complexes .

4.2. Technical Validation

  • Specificity: Antibodies are typically validated using knockout strains (e.g., comparing wild-type vs. YML009W-BΔ lysates) to confirm signal absence in null mutants .

  • Cross-Reactivity: As a polyclonal antibody, YML009W-B may exhibit off-target binding; rigorous validation against related yeast strains is advised .

4.3. Comparative Insights

Studies on analogous antibodies (e.g., anti-CHIKV or anti-SARS-CoV-2 monoclonal antibodies) highlight the importance of epitope mapping and neutralization assays . While YML009W-B is not therapeutic, its development follows similar principles of antigen design and host immunization .

Challenges and Future Directions

  • Functional Annotation: Further studies are needed to characterize the YML009W-B protein’s biological role.

  • Therapeutic Potential: Unlike monoclonal antibodies targeting human pathogens (e.g., Epstein-Barr virus or SARS-CoV-2 ), YML009W-B remains confined to basic research.

References

  1. Cusabio. Custom Antibodies for Sale, Gene Name Starting with Y Page 27. Accessed March 13, 2025.

  2. Britannica. Antibody | Definition, Structure, Function, & Types. March 7, 2025.

  3. NIH. Experimental Monoclonal Antibodies Show Promise Against Epstein-Barr Virus. October 27, 2022.

  4. Abcam. Anti-ProCathepsin B Antibody [EPR24353-25] (ab270998).

  5. PMC. AbDb: Antibody Structure Database—A Database of PDB-Derived Antibody Structures. April 27, 2018.

  6. bioRxiv. YAbS: The Antibody Society’s Antibody Therapeutics Database. February 10, 2025.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YML009W-B; YML010W-A; Putative uncharacterized protein YML009W-B
Target Names
YML009W-B
Uniprot No.

Target Background

Database Links

STRING: 4932.YML009W-B

Subcellular Location
Membrane; Single-pass membrane protein.

Q&A

What is YML009W-B and why is it important in research applications?

YML009W-B is a genetic element in Saccharomyces cerevisiae that has been identified in studies related to oxidative stress responses . Its significance stems from its potential role in cellular defense mechanisms against reactive oxygen species. Antibodies targeting this protein are valuable tools for investigating stress response pathways, protein localization, and expression levels during oxidative challenges. When designing experiments with YML009W-B antibodies, researchers should consider both the genetic context (such as strain variations) and environmental conditions that might affect protein expression.

What validation methods should be used to confirm YML009W-B antibody specificity?

Antibody validation requires multiple complementary approaches to ensure specificity:

  • Western blot analysis comparing wild-type and knockout cell lysates (essential for demonstrating specificity)

  • Immunoprecipitation followed by mass spectrometry to confirm target capture

  • Immunofluorescence comparing localization patterns in wild-type versus knockout cells

  • Cross-reactivity testing against closely related proteins

The YCharOS initiative demonstrates that proper antibody validation should include knockout controls, as the best-performing antibodies show bands only in wild-type samples and not in knockout controls . For yeast proteins like YML009W-B, validation in different strain backgrounds is particularly important to account for genetic variation.

How do experimental conditions affect YML009W-B detection by antibodies?

Experimental ConditionPotential Impact on DetectionOptimization Strategy
Oxidative stress levelAltered protein expression or modificationsTitrate stress agent (e.g., H₂O₂) and monitor time course
Sample preparationProtein degradation or epitope maskingInclude protease inhibitors; optimize lysis buffers
Fixation methodEpitope accessibilityCompare paraformaldehyde vs. methanol fixation
Genetic backgroundStrain-specific variationsInclude multiple reference strains

Researchers should note that oxidative stress conditions may induce post-translational modifications in YML009W-B that could affect antibody recognition. Similar to other proteins involved in stress responses, these modifications might include phosphorylation, acetylation, or oxidation of specific residues . Careful optimization of experimental conditions is therefore essential for consistent antibody performance.

How can researchers address potential cross-reactivity between YML009W-B antibodies and related yeast proteins?

Cross-reactivity is a significant concern in antibody-based detection systems, particularly for proteins that share homologous domains. To address this issue:

  • Perform epitope mapping to identify the specific binding region of the antibody

  • Conduct competitive binding assays with recombinant proteins

  • Utilize multiple antibodies targeting different epitopes of YML009W-B

  • Implement siRNA knockdown or CRISPR knockout controls to verify specificity

The high prevalence of self-reactive antibodies (55-75%) produced during B cell development underscores the importance of rigorous specificity testing. When developing or selecting antibodies for YML009W-B, researchers should consider mapping the exact epitope to ensure it doesn't overlap with conserved regions in related proteins.

What are the optimal conditions for using YML009W-B antibodies in chromatin immunoprecipitation (ChIP) experiments?

ChIP experiments with YML009W-B antibodies require careful optimization:

  • Crosslinking conditions: Test both formaldehyde (1-3%) and dual crosslinkers (formaldehyde + disuccinimidyl glutarate) for optimal protein-DNA fixation

  • Chromatin fragmentation: Sonication parameters should be optimized to yield fragments of 200-500 bp

  • Antibody concentration: Titrate antibody amounts (typically 2-10 μg per ChIP reaction)

  • Washing stringency: Optimize salt concentration in wash buffers to reduce background while maintaining specific signals

When analyzing ChIP-seq data for YML009W-B, researchers should incorporate controls for regions associated with oxidative stress response, as indicated by studies in yeast showing relationship between oxidative stress tolerance and various genetic elements . The ChIP assay protocol should be similar to that described in oxidative stress research methodologies (B.12.9 Chromatin Immunoprecipitation (ChIP) Assay) .

How should researchers interpret Western blot patterns when detecting YML009W-B under different stress conditions?

When interpreting Western blot results for YML009W-B:

  • Multiple bands may represent post-translational modifications, particularly under oxidative stress

  • Band intensity changes across different stress conditions may indicate regulation at protein stability level

  • Mobility shifts may indicate phosphorylation or other modifications

According to YCharOS antibody characterization standards, a selective antibody might display multiple wild-type bands representing truncated splice isoforms, multimers, or post-translationally modified forms of the protein . For YML009W-B specifically, researchers should correlate Western blot patterns with the known stress response pathways in yeast, potentially involving oxidative stress response elements like those regulated by YAP1, which appears in the same context as YML009W-B in the literature .

How can YML009W-B antibodies be used to investigate protein interactions during oxidative stress response?

Investigating protein interactions during oxidative stress response requires multiple complementary approaches:

  • Co-immunoprecipitation (Co-IP) with YML009W-B antibodies followed by mass spectrometry to identify interaction partners

  • Proximity ligation assays to visualize interactions in situ

  • FRET/BRET assays to monitor dynamic interactions in living cells

  • Reciprocal Co-IP experiments to confirm interactions from both perspectives

Research on oxidative stress tolerance in yeast has revealed complex genetic and molecular mechanisms , suggesting that YML009W-B may participate in protein complexes that respond to reactive oxygen species. When designing Co-IP experiments, researchers should consider the cellular damage control mechanisms for reactive oxygen and nitrogen species (RONS) effects, including proteasomal degradation of oxidized proteins and DNA repair mechanisms .

What contradictions exist in the literature regarding YML009W-B function, and how might antibody-based approaches resolve these?

While specific contradictions regarding YML009W-B are not detailed in the provided search results, research on oxidative stress response in yeast often reveals complex and sometimes contradictory findings about gene function. Antibody-based approaches can help resolve such contradictions through:

  • Temporal analysis of protein expression and modification patterns during stress response

  • Subcellular localization studies under different conditions

  • Interaction network mapping to place YML009W-B in functional pathways

  • Identification of post-translational modifications that may explain different functional states

Given that YML009W-B appears in research related to oxidative stress tolerance , researchers should consider whether apparent contradictions might reflect strain-specific differences, as illustrated by research showing multiple genetic architectures can lead to similar phenotypic outcomes in stress response .

How can AI-based approaches enhance the development and application of YML009W-B antibodies?

AI technologies are revolutionizing antibody research and can be applied to YML009W-B studies:

  • De novo generation of antigen-specific antibody sequences targeting specific YML009W-B epitopes

  • Prediction of optimal antibody CDRH3 sequences using germline-based templates

  • Structure-based epitope prediction to identify accessible regions unique to YML009W-B

  • In silico affinity maturation to improve binding properties

Recent advances in AI-based antibody development have demonstrated efficiency in generating antigen-specific antibodies, as shown by successful application to SARS-CoV-2 targets . These approaches can bypass the complexity of natural antibody generation while achieving similar specificity. For yeast proteins like YML009W-B, computational prediction of antibody-accessible epitopes could significantly improve targeting strategies.

What are the best practices for multiplexed detection systems involving YML009W-B antibodies?

Multiplexed detection involving YML009W-B antibodies requires careful planning:

  • Select compatible antibodies from different host species to allow simultaneous detection

  • Use directly conjugated primary antibodies with distinct fluorophores to minimize cross-reactivity

  • Implement spectral unmixing for fluorescence microscopy to resolve overlapping emission spectra

  • Include appropriate single-stain controls for accurate compensation

When designing multiplexed experiments to study YML009W-B in the context of oxidative stress response, researchers should consider including markers for proteasome activity and DNA damage, as these are key cellular systems that act as damage control mechanisms for the effects of reactive oxygen and nitrogen species .

How should researchers approach quantitative analysis of YML009W-B expression or modifications in high-throughput experiments?

Quantitative analysis in high-throughput experiments requires rigorous methodology:

Analytical ApproachKey ConsiderationsNormalization Strategy
Western blot quantificationLinear dynamic range, exposure timeHousekeeping proteins stable under oxidative stress
Mass spectrometryPeptide selection, ionization efficiencyStable isotope labeling (SILAC) or iBAQ
Image-based analysisBackground subtraction, threshold settingCell size, number, and morphology
Flow cytometryGating strategy, fluorophore brightnessReference populations, beads

For yeast studies involving YML009W-B, researchers should incorporate appropriate controls that account for the potential influence of aneuploidies, which can be conditionally beneficial in certain stress conditions . Statistical analysis should follow approaches used in quantitative genetics research on stress responses, where chemical treatment is used to induce specific types of stress .

What considerations are important when developing antibodies against post-translationally modified forms of YML009W-B?

Developing modification-specific antibodies requires special attention to:

  • Peptide design incorporating the specific modification of interest

  • Stringent negative control testing against unmodified protein

  • Validation in biological contexts where the modification is induced or inhibited

  • Cross-reactivity testing against similar modifications on related proteins

For YML009W-B, which appears in oxidative stress research contexts , potential modifications might include oxidation of cysteine residues, phosphorylation at stress-responsive sites, or ubiquitination related to protein quality control during stress. Researchers developing modification-specific antibodies should consider the dynamic nature of these modifications during stress response and recovery phases.

How might single-cell analysis techniques using YML009W-B antibodies reveal heterogeneity in stress responses?

Single-cell analysis with YML009W-B antibodies can reveal important insights:

  • Mass cytometry (CyTOF) using metal-conjugated antibodies can quantify YML009W-B alongside dozens of other markers

  • Single-cell Western blot techniques enable protein quantification in individual cells

  • Imaging mass cytometry can map YML009W-B localization within tissue context

  • Microfluidic techniques can correlate YML009W-B levels with single-cell transcriptomics

Stress response heterogeneity is an important consideration in yeast populations, as indicated by research showing that multiple genetic architectures can lead to similar phenotypic outcomes in stress response . Single-cell approaches can help determine whether YML009W-B expression or modification patterns contribute to this heterogeneity.

What are the emerging technologies for improving YML009W-B antibody specificity and sensitivity?

Emerging technologies for antibody improvement include:

  • AI-based antibody sequence optimization targeting YML009W-B-specific epitopes

  • Nanobody and single-domain antibody development for improved accessibility to structural epitopes

  • Recombinant antibody engineering with site-specific modifications to enhance stability

  • Proximity-based labeling combined with antibody detection for enhanced specificity

Recent advances in AI-based technology for de novo generation of antigen-specific antibody CDRH3 sequences using germline-based templates demonstrate how computational approaches can complement traditional antibody development methods . These technologies could potentially be applied to generate highly specific antibodies against YML009W-B or its modified forms.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.